日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reduced lipid metabolite abundance in human pancreatic cancer and matched serum samples following neoadjuvant FOLFIRINOX treatment

新辅助FOLFIRINOX治疗后,人胰腺癌及其匹配血清样本中脂质代谢物丰度降低

Amrutkar, Manoj; Guttorm, Sander Johannes Thorbjørnsen; Labori, Knut Jørgen; Rootwelt, Helge; Elgstøen, Katja Benedikte Prestø; Gladhaug, Ivar P; Verbeke, Caroline S

Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer

对肿瘤组织和配对血清样本进行全局代谢组学分析,以鉴定预测人胰腺癌新辅助FOLFIRINOX治疗反应的生物标志物

Amrutkar, Manoj; Guttorm, Sander Johannes Thorbjørnsen; Finstadsveen, Anette Vefferstad; Labori, Knut Jørgen; Eide, Lars; Rootwelt, Helge; Elgstøen, Katja Benedikte Prestø; Gladhaug, Ivar P; Verbeke, Caroline S

Proteomic Characterization of Primary Human Pancreatic Cancer Cell Lines Following Long-Term Exposure to Gemcitabine.

长期暴露于吉西他滨后原代人胰腺癌细胞系的蛋白质组学特征分析。

Amrutkar Manoj, Li Yuchuan, Finstadsveen Anette Vefferstad, Verbeke Caroline S, Gladhaug Ivar P

Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis

胰腺星状细胞诱导的胰腺癌吉西他滨耐药性与 LDHA 和 MCT4 介导的增强糖酵解有关

Manoj Amrutkar, Kjersti Berg, Aina Balto, Miguel G Skilbrei, Anette V Finstadsveen, Monica Aasrum, Ivar P Gladhaug, Caroline S Verbeke

Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells

脂肪酸可消除胰腺癌细胞中胆固醇通量抑制引起的生长抑制作用

Yuchuan Li, Manoj Amrutkar, Anette Vefferstad Finstadsveen, Knut Tomas Dalen, Caroline S Verbeke, Ivar P Gladhaug

Neoadjuvant chemotherapy is associated with an altered metabolic profile and increased cancer stemness in patients with pancreatic ductal adenocarcinoma

新辅助化疗与胰腺导管腺癌患者的代谢特征改变和癌症干细胞增加有关

Manoj Amrutkar, Caroline S Verbeke, Anette Vefferstad Finstadsveen, Linda Dorg, Knut Jørgen Labori, Ivar P Gladhaug

Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer

星状细胞促进生长允许性代谢重编程并促进胰腺癌对吉西他滨的化学耐药性

Manoj Amrutkar, Ivar P Gladhaug

Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence

胰腺癌的形态异质性反映了结构和功能的差异

Petra Sántha, Daniela Lenggenhager, Anette Finstadsveen, Linda Dorg, Kristin Tøndel, Manoj Amrutkar, Ivar P Gladhaug, Caroline Verbeke

Establishment and Characterization of Paired Primary Cultures of Human Pancreatic Cancer Cells and Stellate Cells Derived from the Same Tumor

源自同一肿瘤的人胰腺癌细胞和星状细胞的配对原代培养物的建立和表征

Manoj Amrutkar, Emma Kristine Larsen, Monica Aasrum, Anette Vefferstad Finstadsveen, Per Arne Andresen, Caroline S Verbeke, Ivar P Gladhaug

Differential Gemcitabine Sensitivity in Primary Human Pancreatic Cancer Cells and Paired Stellate Cells Is Driven by Heterogenous Drug Uptake and Processing

人类原发性胰腺癌细胞和配对星状细胞对吉西他滨的敏感性差异是由异质性药物摄取和加工引起的

Manoj Amrutkar, Nils Tore Vethe, Caroline S Verbeke, Monica Aasrum, Anette Vefferstad Finstadsveen, Petra Sántha, Ivar P Gladhaug